-The Hindu The local community, especially men, have been roped into a project in 22 Maharashtra villages to stop female foeticide and discrimination against the girl child In India, the irony never ceases. While the country venerates several female deities of wealth, learning and valour, it also practises blatant discrimination against the girl child. Going by statistics revealed by the census and various government as well as independent studies, it has been...

-The Times of India CHANDIGARH: The Haryana government has still not implemented the order of whistleblower IAS officer Ashok Khemka, cancelling the mutation of Robert Vadra-DLF land deal on October 15. And now Gurgaon deputy commissioner PC Meena has sought advice from the Hooda government on Khemka's order, which claimed the mutation was not sanctioned by a "competent" authority. Meena, in his letter, has also justified the land deal and claimed...

-The Hindustan Times Underprivileged people of Muktsar district, the home turf of Punjab chief minister Parkash Singh Badal, received a lion's share for construction of houses in 2011 in the run-up to the assembly elections, it has emerged. Funds to the tune of over Rs. 40 crore were pumped into Muktsar district alone from the social infrastructure fund (SIF) to help economically weaker sections (EWS) construct or repair their houses, while five districts,...

-The Hindu Fresh documents with The Hindu show clear and undeniable links between the sudden transfer of senior IAS official Ashok Khemka and his initiation of a probe specifically related to Congress president Sonia Gandhi’s son-in-law Robert Vadra and his companies, contrary to the Haryana government attempts to establish that the two events were unrelated. The documents belie the claims made by the Haryana government that Mr. Khemka acted on the Vadra-DLF...

-The Times of India Medicines in India may not be sold under brand names in the near future. In its biggest move to push generic drugs and do away with brand names, the Union health ministry has ordered states to stop issuing licence for the manufacture or sale of drugs on the basis of their brand name. All pharmaceutical firms applying for licence to market or manufacture fixed dose combination (FDC) drugs will...